Chen Yulong, Xu Cangbao, Wei Yahui, Zhang Yaping, Cao Ailan
Shaanxi Pharmaceutical Development Center, Shaanxi Pharmaceutical Holding Group Co., Ltd., Xi'an, Shaanxi 710075, P.R. China; Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, Shaanxi 710021, P.R. China.
Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, Shaanxi 710021, P.R. China; Department of Clinical Sciences, Division of Experimental Vascular Research, Lund University, S-22184 Lund, Sweden.
Exp Ther Med. 2016 Oct;12(4):2241-2246. doi: 10.3892/etm.2016.3605. Epub 2016 Aug 22.
Resveratrol (Res) is a specific agonist of sirtuin 1, and has many cardioprotective effects. Although Res is able to relax various vascular beds, its pharmacological properties in rat superior mesenteric arteries and the underlying mechanism are not well clarified. The aim of present study was to investigate the vasorelaxant effects of Res on rat superior mesenteric arteries and the mechanisms involved. The isometric tension of rat superior mesenteric arterial rings was recorded using myography. It was found that Res concentration-dependently relaxed endothelium-intact superior mesenteric artery rings pre-contracted by phenylephrine hydrochloride (E, 97.66±0.79%; pD, 4.30±0.14) or KCl (E, 101.3±0.6%; pD, 4.12±0.03). The vasorelaxant effect of Res on the superior mesenteric artery rings was partially endothelium-dependent. N-nitro-L-arginine methyl ester (100 µM) significantly inhibited the Res-induced vasorelaxant effect. However, 1H-[1,2,4]oxadiazolo[4,3-a] quinoxalin-1-one (10 µM) and indomethacin (5 µM) each had no effect on the Res-induced vasorelaxation. In artery rings without endothelium, the vasorelaxation induced by Res was attenuated by 4-aminopyridine (100 µM) and glibenclamide (10 µM). However, barium chloride dehydrate (10 µM) and tetraethylammonium chloride (1 mM) did not affect the vasorelaxation induced by Res. Moreover, Res also inhibited the contraction induced by an increase in external calcium concentration in Ca-free medium plus KCl (60 mM). These results suggest that Res induces relaxation in superior mesenteric arterial rings through an endothelium-dependent pathway, involving nitric oxide release, and also through an endothelium-independent pathway, with opening of voltage-dependent K channels and ATP-sensitive K channels and blockade of extracellular Ca influx.
白藜芦醇(Res)是沉默信息调节因子1的特异性激动剂,具有多种心脏保护作用。尽管Res能够舒张各种血管床,但其在大鼠肠系膜上动脉中的药理特性及潜在机制尚未完全阐明。本研究的目的是探讨Res对大鼠肠系膜上动脉的舒张作用及其相关机制。采用肌张力测定法记录大鼠肠系膜上动脉环的等长张力。结果发现,Res能浓度依赖性地舒张由盐酸去氧肾上腺素(舒张率,97.66±0.79%;pD,4.30±0.14)或氯化钾(舒张率,101.3±0.6%;pD,4.12±0.03)预收缩的内皮完整的肠系膜上动脉环。Res对肠系膜上动脉环的舒张作用部分依赖于内皮。N-硝基-L-精氨酸甲酯(100 μM)显著抑制Res诱导的舒张作用。然而,1H-[1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮(10 μM)和吲哚美辛(5 μM)对Res诱导的血管舒张均无影响。在无内皮的动脉环中,Res诱导的血管舒张被4-氨基吡啶(100 μM)和格列本脲(10 μM)减弱。然而,二水合氯化钡(10 μM)和四乙铵氯化物(1 mM)对Res诱导的血管舒张无影响。此外,Res还抑制了无钙培养基加氯化钾(60 mM)中细胞外钙浓度升高诱导的收缩。这些结果表明,Res通过依赖于内皮的途径(涉及一氧化氮释放)以及不依赖于内皮的途径(通过开放电压依赖性钾通道和ATP敏感性钾通道以及阻断细胞外钙内流)诱导肠系膜上动脉环舒张。